Advertisement

Häufige diagnostische Kategorien

  • Margot Schmitz

Zusammenfassung

Während in der Medizin die Ursache und Entstehungsweise (Pathogenese) vieler Symptome mehrdeutig ist (z.B. Fieber), sind in der Psychiatrie darüber hinaus auch die meisten Syndrome pathogenetisch mehrdeutig. Zum Beispiel kann ein depressives Geschehen körperlich (Diabetes), körperlich-funktionell (z.B. Neurotransmitterstörung bei Psychosen), oder umweltbedingt (seelische Krise) begründbar sein. Dazu kommt, dass die Ursache und Entstehungsweise einiger wichtiger psychiatrischer Erkrankungen noch unklar ist. Das Zusammenspiel von Ursache, Auslöser und aufrechterhaltenden Faktoren psychischer Störungen hat aber wesentliche Bedeutung für die Diagnose und eine umfassende Therapie.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. American Psychiatric Association (2001) Practice guidelines for the treatment of patients with borderline personality disorder. Am J Psychiatry 158(suppl) 10:1–52Google Scholar
  2. Amsterdam JD (1991) Refractory depression; advances in neuropsychiatry and psychopharmacology, vol 2. Raven, New YorkGoogle Scholar
  3. Angst J (1987) Switch from depression to mania, or from mania to depression: role of psychotropic drugs. Psychopharmacol Bull 23:66–67PubMedGoogle Scholar
  4. Appels A, Bär F, Bär J et al (2000) Inflammation, depression and coronary artery disease. Psychosom Med 62:601–605PubMedGoogle Scholar
  5. Ballanger JC (1988) The clinical of carbamazepine in affective disorders. J Clin Psychiat 49(Suppl):13–19Google Scholar
  6. Ban TA, Hippius H (1988) Thirty years CINP. Springer, Berlin Heidelberg New YorkCrossRefGoogle Scholar
  7. Benkert O, Hippius H (1986) Psychiatrische Pharmakotherapie. Springer, Berlin Heidelberg New YorkGoogle Scholar
  8. Ben-Tovim DI, Walker K, Gilchrist P et al (2001) Outcome in patients with eating disorders: a 5 year study. Lancet 357:1254–1257PubMedCrossRefGoogle Scholar
  9. Berndt ER, Koran LM, Finkelstein SN et al (2000) Lost human capital from early onset chronic depression. Am J Psychiatry 157:940–947PubMedCrossRefGoogle Scholar
  10. Berner P (1982) Psychiatrische Systematik. Huber, Bern Stuttgart WienGoogle Scholar
  11. Black DW, Winokur G, Nasrallah A (1987) The treatment of depression — electroconvulsive therapy versus antidepressants — a naturalistic evaluation of 1495 patients. Compr Psychiat 28:169–182 (10)PubMedCrossRefGoogle Scholar
  12. Bouton ME, Mineka B, Barlow DH (2001) A modern learning theory perspective on the etiology of panic disorder. Psychol Rev 108:4–32PubMedCrossRefGoogle Scholar
  13. Boyer P (2000) Do anxiety and depression have a common pathophysiological mechanism? Acta Psychiat Scand (Suppl 406) 24–29Google Scholar
  14. Byerley WF, Reimherr FW, Wood DR, Grosser BL (1988) Fluoxetine, a selective serotonin uptake inhibitor, for the treatment of outpatients with major depression. J Clin Psychopharmacol 8:112–115PubMedCrossRefGoogle Scholar
  15. Chan CH, Janicak PG, Davis JM et al (1987) Response of psychotic and non psychotic depressed patients to tricyclic antidepressants. J Clin Psychiat 48:197–200 (7)Google Scholar
  16. Checkley S (1988) Monoamines, depression and antidepressant drugs. Pharmacopsychiatry 21:6–8PubMedCrossRefGoogle Scholar
  17. Cohen S, Khan A, Johnson S (1987) Pharmacological management of manic psychosis in an unlocked setting. J Clin Psychopharmacol 7:261–263PubMedGoogle Scholar
  18. Conklin HM, Curtis CE, Katsanis J, Iacono WG (2000) Verbal working memory impairment in schizophrenia patients and their first degree relatives: evidence from the digit span task. Am J Psychiatry 157:275–277PubMedCrossRefGoogle Scholar
  19. Ellison JM (1989) The psychotherapist’s guide to pharmacotherapy. Yearbook Med Publ, Chicago London Boca RatonGoogle Scholar
  20. Feighner JP, Boyer WF (1991) Selective serotonin re-uptake inhibitors. John Wiley & Sons, Chichester New YorkGoogle Scholar
  21. Friedmann A (1992) Leitfaden der Psychiatrie. Maudrich, Wien München BerlinGoogle Scholar
  22. Grenn AR (1988) The mechanism of action of antidepressant treatments: basic aspect. Pharmacopsychiatry 21:3–5CrossRefGoogle Scholar
  23. Haag H, Heidorn A, Haag M, Greil W (1987) Sequence of affective polarity and lithium responses: preliminary report on Munich sample. Prog Neuropsychopharmacol Biol Psychiat 11:205–208CrossRefGoogle Scholar
  24. Haase HJ (1982) Therapie mit Psychopharmaka und anderen psychotropen Medikamenten. Schattauer, StuttgartGoogle Scholar
  25. Jaspers K (1973) Allgemeine Psychopathologie. Springer, Berlin Heidelberg New YorkGoogle Scholar
  26. Kasen S, Cohen P, Skodol AE, Johnson JG, Brook JS (1999) Influence of Child and Adolescent Psychiatric Disorder on Young Adult Personality Disorder. Am J Psychiatry156:10, 1529–1535PubMedGoogle Scholar
  27. Katona C (2000) Managing depression and anxiety in the elderly patient. European Neuropsychopharm 10(Suppl 4) 427–432CrossRefGoogle Scholar
  28. Kessler RC (2000) The epidemiology of pure and comorbid generalized anxiety disorder: a review and evaluation of recent research. Acta Psychiatr Scand 102 (suppl 406):7–13CrossRefGoogle Scholar
  29. Kessler RC (2003) Epidemiology of psychiatric comorbidity. In: Tusang MT, Tohen 6M, Zahner GEP (eds). Textbook in psychiatric epidemiology, 2nd ed, Wiley, New YorkGoogle Scholar
  30. Langer G, Heimann H (1983) Psychopharmaka. Springer, WienCrossRefGoogle Scholar
  31. Laux G (1988) Psychopharmaka — ein Leitfaden. Fischer, Stuttgart New YorkGoogle Scholar
  32. Linde OK (1988) Pharmakopsychiatrie im Wandel der Zeit. Tilia, KlingenmünsterGoogle Scholar
  33. Matussek N, Hippius H (1984) Tabulae psychiatricae et psychopharmacologicae. Aesophus, BaselGoogle Scholar
  34. McGorry PD, Yung A, Phillips LJ et al (2002) A randomized controlled trial of interventions designed to reduce the risk of progression to first episode psychosis in a clinical sample with subthreshold symptoms. Arch Gen Psychiatry 59:921–928PubMedCrossRefGoogle Scholar
  35. Meryn S (1991) Schade, daß du schon gestorben bist. Strategien für ein persönliches Gesundheitsmanagement. Quintessenz, MünchenGoogle Scholar
  36. Morey LC, Gunderson JG, Quigley BD, Shea MT (2002) The representation of borderline, avoident, obsessive-compulsive, and schizotypal personality disorders by the five-factor model. J Personal Disord 16:215–234CrossRefGoogle Scholar
  37. Muller B (1988) Psychotropics 88/89. Lundbeck, Heerlen NethGoogle Scholar
  38. Müller C (1973) Lexikon der Psychiatric Springer, Berlin Heidelberg New YorkCrossRefGoogle Scholar
  39. Nutt D (2000) Treatment of depression and concomitant anxiety. European Neuropsychopharm 10(suppl 4):433–437CrossRefGoogle Scholar
  40. Pare CMB (1987) Monoamine oxidase inhibitors in the treatment of affective disorders. Psychiat Ann 17:309–335Google Scholar
  41. Paterniti S et al (2001) Sustained anxiety linked to progression of carotid atherosclerosis in men. Arterioscler Thromb Vasc Biol 21:136–141PubMedCrossRefGoogle Scholar
  42. Paykel ES, Vanwoerkom AE (1987) Pharmacologic treatment of resistant depression. Psychiat Ann 17:327–335Google Scholar
  43. Pöldinger W, Gander G (1979) Psychopharmaka in der Praxis. Roche, ParisGoogle Scholar
  44. Pöldinger W, Schmidlin P, Wider F (1983) Index psychopharmacorum. Huber, BernGoogle Scholar
  45. Rees I (1987) Developments in the pharmacologic treatment of affective disorders. Psychiat Ann 17:297–300Google Scholar
  46. Saletu B (1989) Biologische Psychiatrie. Thieme, Stuttgart New YorkGoogle Scholar
  47. Scott J, Barker WA, Eccleston D (1988) The Newcastle chronic depression study: patient characteristics and factors associated with chronicity. Br J Psychiat 152:28–33CrossRefGoogle Scholar
  48. Skodol AE, Siever LJ, Livesley WJ et al (2002) The borderline diagnosis II: biology, genetics and clinical course. Biol Psychiatry 51:951–963PubMedCrossRefGoogle Scholar
  49. Spector R, Rogers H, Roy D (1984) Psychiatry: common drug treatments; practical problems in medicine. Dunitz, LondonGoogle Scholar
  50. Spijker J, Gijl RV, de Graaf R, Nolen WA (2001) Determinants of poor 1 year outcome of DSM III R major depression in the general population: results of the Netherlands Mental Health Survey and Incidence Study (NEMESIS). Acta Psychiat Scand 103:122–130PubMedCrossRefGoogle Scholar
  51. Wehr T (1987) Can antidepressants cause mania and worsen the course of affective illness. Am J Psychiat 144:1403–1411PubMedGoogle Scholar
  52. Weickert TC, Goldberg TE, Gold JM et al (2000) Cognitive impairments in patients with schizophrenia displaying preserved and compromised intellect. Arch Gen Psychiatry 57:907–913PubMedCrossRefGoogle Scholar
  53. Wittchen HU, Kessler RC, Pfister H, Lieb M (2000) Why do people with anxiety disorders become depressed? A prospective longitudinal community study. Acta Psychiatr Scand (suppl 406): 14–23Google Scholar
  54. Young A (2001) Primary care physicians in US not managing depressive, anxiety disorders well; http://psychiatry.medscape.com/reuters/prof/2001/01/01.16/20010115publ003.html

Copyright information

© Springer-Verlag Berlin Heidelberg 2004

Authors and Affiliations

  • Margot Schmitz
    • 1
    • 2
  1. 1.WienAustria
  2. 2.WienAustria

Personalised recommendations